Recalls / Active ingredient / Dabigatran Etexilate Mesylate
Dabigatran Etexilate Mesylate
4 FDA drug recalls involving the active ingredient “Dabigatran Etexilate Mesylate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-12-12 | Class II | Dabigatran Etexilate, 75 mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., IND | Ascend Laboratories, LLC |
| 2024-12-12 | Class II | Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., IND | Ascend Laboratories, LLC |
| 2023-03-14 | Class II | Dabigatran Etexilate Capsules, 75 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laboratories Ltd | Ascend Laboratories, LLC |
| 2023-03-14 | Class II | Dabigatran Etexilate 150mg Capsules, 150 mg, Rx Only, 60 Capsules per bottle, Manufactured by: Alkem Laborato | Ascend Laboratories, LLC |